Last update 01 Jun 2026

Beijing Rexiu Biotechnology Co., Ltd.

Private Company|2016|Guangdong Sheng, China

Overview

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Immune System Diseases2
Endocrinology and Metabolic Disease2
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Recombinant polypeptide1
Fusion protein1
Protein drugs1
Top 5 TargetCount
HSP90B1(heat shock protein 90 beta family member 1)2

Related

4
Drugs associated with Beijing Rexiu Biotechnology Co., Ltd.
HS-03
Target-
Mechanism-
Active Org.
Foshan Rexiu Biotechnology Co., Ltd.
Originator Org.
Foshan Rexiu Biotechnology Co., Ltd.
Active Indication
Amyotrophic Lateral Sclerosis
Inactive Indication-
Drug Highest PhaseEarly Phase 1
First Approval Ctry. / Loc.-
First Approval Date-
Gp96
Target-
Mechanism-
Active Org.
Foshan Rexiu Biotechnology Co., Ltd.
Originator Org.
Foshan Rexiu Biotechnology Co., Ltd.
Active Indication
Systemic Lupus Erythematosus
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
WO2024021383
Patent Mining
Target
HSP90B1
Mechanism-
Active Org.
Foshan Rexiu Biotechnology Co., Ltd.
Originator Org.
Foshan Rexiu Biotechnology Co., Ltd.
Active Indication
Nutritional and Metabolic Diseases
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
7
Clinical Trials associated with Beijing Rexiu Biotechnology Co., Ltd.
ChiCTR2500108815
/ RecruitingNot ApplicableIIT
A single-center, single-arm, open-label, prospective clinical study of HS-03 injection in the treatment of amyotrophic lateral sclerosis (ALS)
ChiCTR2400079885
/ SuspendedEarly Phase 1IIT
A single-arm, single-center, open-label clinical study of HS-03 injection in the treatment of amyotrophic lateral sclerosis
ChiCTR2300072934
/ RecruitingNot ApplicableIIT
A single-center, single-arm, open-label clinical study of placental gp96 injection to enhance immunity
100 Clinical Results associated with Beijing Rexiu Biotechnology Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Beijing Rexiu Biotechnology Co., Ltd.
Login to view more data
100 Deals associated with Beijing Rexiu Biotechnology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Beijing Rexiu Biotechnology Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 12 Sep 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
2
1
Preclinical
Early Phase 1
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
HS-03
Amyotrophic Lateral Sclerosis
More
Early Phase 1
Gp96
Systemic Lupus Erythematosus
More
Preclinical
CN116769046
 ( HSP90B1 )Patent Mining		Rare Diseases
More
Discovery
WO2024021383
 ( HSP90B1 )Patent Mining		Nutritional and Metabolic Diseases
More
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free